Stock UniverseDerived research view · source repositories remain read-only

Takeda Pharmaceutical Company Limited (TAK)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Qualified
Selection Score
38.04
Global Rank
688
Market Cap
58.90B
Latest Close
15.60
RS Composite
-9.96% · G#2089

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-6.70%
3M
-12.75%
6M
9.01%
1Y
3.79%
3Y
5.20%
5Y
-2.49%
10Y
-22.75%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 3.51M · 30-day average: 3.09M · Max drawdown over stored range: -59.60%

Research Snapshot

Relative Strength vs SPX

RS Composite-9.96%
20D RS-6.89%
60D RS-22.88%
120D RS1.41%
Global RS Rank2089 · 37.73% percentile
Qualified+ RS Rank783 · 37.76% percentile
Group ScopeQualified+
Primary RS Rank204 · 55.46% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank98 / 701
Primary Percentile86.16
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for TAK.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue319781231978123569006402747842637624581551
Revenue Growth (YoY)-2.837%-2.837%11.608%12.846%5.867%7.453%
Gross Profit21841572441698277431528322573010132
Operating Income424047600062619667499475562936
Free Cash Flow899725899725999853836499540924856387
Free Cash Flow Per Share285.8925465368784571.785633.954532.845342.283533.467
EPS (Diluted) GAAP238.96145.87201.9491.1667.23
EPS Growth745.876%745.876%-38.956%38.438%-54.858%-26.251%
EPS Non-GAAP
Gross Margin68.9066%68.302%68.414%68.885%66.426%65.701%
Operating Margin15.9255%13.261%16.813%15.386%11.714%12.287%
Profit Margin11.7634%11.758%6.446%7.871%3.379%2.356%
Free Cash Flow Margin28.1356%28.136%28.015%20.77%12.687%18.692%
Shares Outstanding (Diluted)3147.0741573.5371577.1691569.8721580.3431605.323
Shares Change (YoY)0.468%0.468%0.231%-0.463%0.667%1.581%

SEC Quarterly Fundamentals

No processed quarterly rows for TAK.